Heavy Metals in Herbal Supplements: The EU Testing Limits European Brands Are Missing
EU Regulation 2023/915 sets binding limits on lead, cadmium, mercury and arsenic in botanical supplements. Most European brands test too late against the wrong spec.
Point clé
EU Regulation 2023/915 sets binding limits on lead, cadmium, mercury and arsenic in botanical supplements. Most European brands test too late against the wrong spec.
Most European herbal supplement brands discover they have a heavy metals problem when a retailer, an Amazon EU compliance team, or a US distribution partner asks for test results. By then, they’ve already printed labels, manufactured stock, and often shipped product. The testing should have happened twelve months earlier — at supplier qualification — and it should have been done against the correct EU legal limits, not a generic “pass/fail” from a Certificate of Analysis that doesn’t reference any specific regulation.
This isn’t an edge case. The European Food Safety Authority (EFSA) has flagged dietary exposure to lead, cadmium, mercury, and inorganic arsenic from plant-based food supplements as a persistent priority concern across multiple contaminant opinions. Commission Regulation (EU) 2023/915 — which repealed and replaced EC No 1881/2006 as the primary EU framework for maximum contaminant levels in food — establishes binding limits that manufacturers are legally responsible for meeting, regardless of where the botanical raw material was grown, harvested, or processed.
And the botanical supplement sector, specifically, is one of the riskiest matrices for heavy metal contamination in all of food manufacturing. Understanding why — and knowing how to test correctly — is the difference between a clean release and a market withdrawal.
The EU Maximum Levels You’re Legally Responsible For
Commission Regulation (EU) 2023/915 consolidates maximum levels (MLs) for a range of contaminants across food categories. For food supplements containing botanical ingredients, four metals demand your immediate attention.
Lead has a maximum level of 3.0 mg/kg for food supplements as a general category. That figure sounds generous until you account for concentration. Many dried root extracts — particularly those sourced from agricultural zones in China, India, or parts of Eastern Europe — test between 1.0 and 4.5 mg/kg in incoming raw material surveys. Concentrate that botanical through a standard 5:1 extraction ratio and the arithmetic becomes uncomfortable fast. Raw herb material at 1.8 mg/kg lead, concentrated fivefold, yields an extract at approximately 9.0 mg/kg — three times over the legal limit in your finished product.
Mercury is capped at 0.1 mg/kg for food supplements not derived from marine sources. EFSA’s dietary exposure models show that even small contributions from non-fish sources matter for sensitive populations, which is why the limit sits where it does. Most encapsulated botanical blends sit comfortably below this threshold — but certain traditional preparations, particularly those containing seeds or resins processed through supply chains using inorganic reagents, do not.
Cadmium limits for plant-based supplements vary by product subcategory under EU 2023/915, with relevant ceilings in the range of 1.0 mg/kg for dried botanical materials in some categories. The variation matters: a supplement brand reformulating from a leaf-based to a root-based raw material may shift between two different applicable limits without realising it.
Inorganic arsenic is regulated strictly for rice-based products at 0.1–0.2 mg/kg under current EU rules, and EFSA’s CONTAM Panel is actively reviewing dietary exposure data to extend tighter limits across broader botanical supplement categories. If your formulation uses rice bran, rice flour, or any rice-derived excipient as a flow agent or bulking ingredient, you need inorganic arsenic-specific testing now — not when the next regulatory amendment lands.
The EFSA risk benchmarks frame how seriously these numbers deserve to be taken. For lead, the Authority established a BMDL01 (the dose associated with a 1% increase in the incidence of an adverse health effect) of just 1.2 µg/kg body weight per day — one of the lowest values in the entire contaminant toxicology literature, reflecting the absence of a true safe threshold for lead exposure. For cadmium, EFSA set a Tolerable Weekly Intake (TWI) of 2.5 µg/kg body weight per week in its 2009 opinion, a value that regular botanical supplement users can meaningfully approach through daily use of contaminated product. These aren’t conservative bureaucratic buffers. They represent real health risk at plausible exposure levels.
Why Botanical Matrices Are Uniquely High-Risk
Heavy metals in botanical ingredients don’t arrive through manufacturing error. They’re a function of soil composition, geological deposits, historical agricultural practices, and irrigation water chemistry — none of which the EU-based formulator controls or often even knows about.
Ashwagandha (Withania somnifera) sourced from Rajasthan can carry lead concentrations reflecting decades of pesticide use in those soils. Turmeric from certain growing zones in Bangladesh shows cadmium variability by a factor of 10 between harvest areas separated by fewer than 50 kilometres. Eleuthero root (Eleutherococcus senticosus), popular in European adaptogen blends, accumulates arsenic from naturally elevated geological deposits across parts of Siberia and northeastern China. These aren’t outlier situations — they’re the documented baseline for how heavy metal content varies in wildcrafted and conventionally farmed botanicals.
The supply chain problem amplifies this. A botanical ingredient passes through a broker in Germany, an importer in France, and a toll manufacturer in Belgium before it reaches your finished product formulation. Each handoff carries a Certificate of Analysis (CoA). But CoAs from Tier 2 and Tier 3 suppliers in international botanical supply chains frequently report heavy metals with no reference to a specific regulatory limit, no identification of the analytical method used, and no indication of which origin lot was actually tested. “Heavy metals: compliant — 0.8 mg/kg” tells you almost nothing useful. Compliant with which regulation? Tested by which method? On which lot from which farm?
That documentation gap is precisely what DGCCRF inspectors in France and their counterparts at national food safety authorities across the EU are trained to expose. A CoA that references no specific EU maximum level is not a compliance record — it’s a liability you’ve accepted without knowing it.
ICP-MS vs. ICP-OES: Why the Analytical Method Is Not a Detail
Two analytical platforms dominate heavy metals testing in botanical matrices: ICP-OES (Inductively Coupled Plasma Optical Emission Spectrometry) and ICP-MS (Inductively Coupled Plasma Mass Spectrometry). Choosing the wrong one is an expensive mistake.
ICP-OES is faster and costs less per sample. ICP-MS achieves detection limits roughly 100 to 1,000 times lower — typically reaching 0.001 mg/kg (1 µg/kg) or below in botanical matrices with proper digestion and calibration. For mercury, which carries a legal ML of 0.1 mg/kg but commonly appears in borderline botanical samples at 0.04–0.09 mg/kg, the difference is critical. An ICP-OES laboratory operating at a detection limit of 0.05 mg/kg will report “not detected” for a sample that ICP-MS would accurately quantify as 0.08 mg/kg — a failing result by EU standards that enters the supply chain as a passing one.
The European standard EN 15763:2009, covering the determination of trace elements in foodstuffs via ICP-MS after pressure digestion, provides the validated methodology that European regulatory authorities expect when analytical results are challenged. The European Pharmacopoeia’s general method 2.4.27 for heavy metals in herbal drug preparations also sets technical benchmarks that laboratories working with botanical supplement matrices should reference. If your supplier’s CoA cites neither of these standards — or cites no method at all — the data it contains isn’t analytically defensible.
Building a Testing Protocol That Actually Protects You
The most common structural mistake in European supplement brands’ testing programmes is testing at the wrong stage, against the wrong specification. Here’s the sequence that makes sense:
-
Test raw botanical materials at supplier qualification. Before you commit to a manufacturing run, screen every incoming botanical for all four priority metals (Pb, Cd, Hg, inorganic As) using ICP-MS, validated against EN 15763:2009 or equivalent. Set internal acceptance specifications tighter than the regulatory ML to account for natural batch-to-batch variation and any concentration steps in your manufacturing process. If you’re producing a 5:1 extract, your raw material internal spec for lead should sit at no more than 0.5–0.6 mg/kg — not 3.0 mg/kg.
-
Test finished product before each batch release. This is where you confirm that extraction, concentration, and blending steps haven’t pushed any metal above its applicable ML. Finished product test data, referenced against EU 2023/915 limits with the testing method identified, is what belongs in your Product Information File and what you present to a competent authority if ever challenged. Don’t rely on raw material data alone.
-
Retest systematically after any origin change. If your botanical supplier shifts growing region — even within the same country, even with the same species — your historical test data no longer represents the new material. Soil composition is hyperlocal. A supplier moving cultivation from one district to another can shift lead content by a factor of 3 without anyone flagging it, because the botanical looks identical. Treat origin change as a trigger for full re-qualification.
Testing frequency beyond this baseline should reflect a documented risk model. High-risk materials — root botanicals, concentrated extracts, ingredients from known high-contamination geographies — warrant per-lot testing or at minimum per-supplier-campaign testing. Lower-risk matrices — leaf materials from documented clean agricultural zones with strong audit histories — may support reduced frequency with appropriate supplier controls.
The Specification No One Writes Early Enough
The most consistent gap we see with European herbal supplement brands isn’t absence of testing. It’s testing that happens too late in the product lifecycle, against a specification that was written after the fact to match what the test happened to show.
A meaningful heavy metals specification isn’t a regulatory limit copied from 2023/915 into a spreadsheet. It accounts for your specific botanical matrix and its known contamination profile, your extraction ratio and how it affects metal concentration, your target distribution markets — EU, US, and Canada each impose different applicable standards in ways that matter when you’re preparing export documentation — your intended daily dose, because the ML in finished product only translates into actual consumer risk in the context of daily exposure, and your supplier diversity, because a specification that works for one origin may fail on another.
Writing that specification before your first manufacturing run, and engaging a qualified laboratory to validate the analytical method against your actual product matrix before you rely on it for release decisions, is the work that separates a compliance programme from a compliance performance.
It’s not technically complicated. But it requires someone with eyes on both the regulatory framework and the analytical reality — and that combination is rarer than it should be in the European botanical supplement sector.
Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team
Talk to our team about EU market entry and botanical testing strategy. Contact us
Related from our network
- Heavy Metal & Contaminant Testing for Supplements — Qalitex Laboratories offers ICP-MS-based heavy metals testing for botanical raw materials and finished dietary supplements, with results referenced against EU, FDA, and USP specifications.
- Botanical Testing for Health Canada NHP Compliance — Androxa supports European brands entering the Canadian NHP market with contaminant testing and supplier qualification documentation aligned to Health Canada requirements.
Rédigé par
Nour AbochamaQuality & Regulatory Advisor, Care Europe | VP Operations, Qalitex
Chemical engineer with 17+ years of experience in laboratory operations, quality assurance, and regulatory compliance across Europe and North America. VP of Operations at Qalitex (ISO/IEC 17025 accredited US laboratory). Through Care Europe, leads the European entry point to a partner-lab network across the USA, Canada, and local Europe — specialising in USA FDA + Health Canada compliance for European exporters and herbal & supplement testing (a rare expertise on the European continent).
Besoin de conseil réglementaire EU ?
Obtenez des conseils d'experts de notre équipe réglementaire française enregistrée SIREN. Support bilingue EN/FR.
Demander un devis →